Text
Combining data about gut-brain–related disorders with genetic and other information provides a powerful approach for predicting Alzheimer’s and Parkinson’s disease.
The findings of a news study reveal how Bifidobacterium evolve and adapt to different hosts, paving the way for targeted therapies such as customized probiotics and diet-based interventions.
CORAL can sample the microbes residing in upper gut in a non-invasive and reliable way, offering a tool for studying the diversity of the microbiota.
Industry
Sponsored by
Through this collaboration, the Icelandic tradition of dairy innovation merges with Italian scientific expertise to drive the future of functional nutrition.
Three promising bacteria were linked to better treatment responses in melanoma patients.
At the 67th ASH, one of hematology’s biggest stages, the Lyon-based biotech will present pivotal Phase 3 results that can bend treatment paradigms.
Targeting the microbiota could be a new way to strengthen gut immunity and develop treatments for inflammatory bowel diseases such as Crohn’s disease.
Antibodies in breast milk “teach” a newborn’s gut immune system to respond appropriately to microbes and maintain intestinal balance without causing unnecessary inflammation.
Profiling the human gut microbiota at the subspecies level, rather than at the species- or strain-level, provides more reproducible insights into how specific bacteria influence health and disease.
Gut bacteria cooperate to convert the dietary antioxidant ergothioneine into a compound that supports energy production.
